我国19省基本药物增补目录比对分析研究

Analysis of essential medicine supplementary lists in 19 provinces of China

通过对我国19省基本药物增补目录药品进行汇总分析,探求各省增补规律,进一步通过对增补目录的具体治疗类别和药品通用名进行频数和比对分析,发现各省遴选频数较高的药品,为下一步基本药物目录的遴选替换工作提供建议。

Through analyzing essential medicine supplementary lists in 19 provinces of China, the law and specific category, medicines＇ general name, and use frequency were compared. We have found the medicines with higher use frequency, and provided advices to the next selection and replacement of the list of essential medicines.